Experience Advanced Pre-loaded
IOL Delivery

In cataract surgery, the moment of IOL implantation is crucial. It affects the placement of the IOL, impacts the state of the incision and sets the stage for post-op refractive outcomes.

With the UltraSert Delivery System, you get:

  • Smooth injection*,1,2
  • Preserved incisions1,3
  • Consistent delivery1,3

Explore the data in the tabs below for a closer look at how.

The AcrySof® IQ IOL with the UltraSert™ Pre-loaded IOL Delivery System

Preserved Incisions with the Depth Guard Nozzle Feature1,3

The depth guard nozzle feature on the UltraSert Delivery System is designed to help you:

  • Control insertion depth1
  • Minimize wound stretch in incisions as small as 2.2 mm3
  • Preserve incision architecture throughout implantation


The depth guard nozzle feature is designed to minimize the probability of wound stretch, tearing or trauma.

The depth guard nozzle feature is designed to minimize the probability of wound stretch, tearing or trauma.1,3

Wound integrity can have a major impact on your procedures and your patients. Data suggests that smaller incision sizes during cataract surgery may result in:

  • Less postoperative inflammation4
  • Less surgically induced astigmatism4
  • More rapid visual and wound rehabilitation5

Preclinical Data Support3

In porcine eyes3

The UltraSert System had minimal wound enlargement and a small final incision size compared to all of the pre-loaded devices tested.3

The UltraSert™ System results in less wound enlargement and a smaller final incision size.

Non-clinical lab study in porcine eyes comparing the pre-loaded injectable IOL delivery system performance of the UltraSert System, the iTec** System and the iSert** System and the manual delivery system performance of the MONARCH® III D System (n=10 porcine eyes per group). Study observations included rate of adherence, rate of in-the-bag delivery, IOL/delivery device interactions, optic and haptic unfolding time, rate of cartridge tip splitting and corneal incision size.


In human cadaver eyes6

Wound enlargement in the UltraSert System group was comparable to that of the MONARCH® III D System.6

The UltraSert™ System results in comparable wound enlargement to the MONARCH® III D Device.

The UltraSert™ System results in a smaller final incision size compared to the MONARCH® III D Device.

Comparative evaluation of corneal wound enlargement caused by UltraSert Pre-loaded Deliver System and MONARCH® III D Delivery System. Non-clinical lab study in porcine eyes (n=10 eyes per group), comparing IOL delivery performance with pre-loaded injectable IOL delivery systems of UltraSert to pre-loaded iTec** and iSert** systems and Monarch manual delivery system. Study observations included rate of adherence, rate of in-the-bag delivery, IOL-delivery device interactions, optic and haptic unfolding time, rate of cartridge tip splitting and corneal incision size.


*Results of prototype testing of the UltraSert Pre-loaded IOL Delivery System in artificial setting by 42 ophthalmologists and 20 nurses/technicians (US Alcon Market Research, Feb. 2015).
Denotes statistical significance for comparison of final incision size as determined by a one-way ANOVA, (p<0.05) compared to the UltraSert™ System.
**Trademarks are the property of their respective owners.


View Important Product Information for
UltraSert Pre-loaded Delivery System +

ULSTRASERT PRE-LOADED IOL DELIVERY SYSTEM WITH THE ACRYSOF® IQ ASPHERIC IOL IMPORTANT PRODUCT INFORMATION

CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician.

INDICATIONS: The AcrySof® IQ aspheric intraocular lens (“AcrySof IQ”) is intended for the replacement of the human lens to achieve visual correction of aphakia in adult patients following cataract surgery. This lens is intended for placement in the capsular bag.

WARNING/PRECAUTION: Use the UltraSert Pre-loaded Delivery System (“UltraSert”) at temperatures between 18o C (64o F) and 23oC (73o F). Use only Alcon viscoelastic qualified for this device. Do not use the UltraSert if the nozzle appears damaged or deformed. Follow the Directions for Use for correct order and sequence of steps to avoid damage to the IOL or the UltraSert.

Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use. Caution should be used prior to lens encapsulation to avoid lens decentrations or dislocations.

Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof® Natural IOL and normal color vision. The effect on vision of the AcrySof® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45o C.

ATTENTION: Reference the Directions for Use for Model AU00T0 for a complete listing of indications, warnings and precautions.

Click here to view the AcrySof® IQ IOL with the UltraSert Preloaded IOL Delivery System Directions For Use (DFU).

ULSTRASERT PRE-LOADED IOL DELIVERY SYSTEM WITH THE ACRYSOF® IQ ASPHERIC IOL IMPORTANT PRODUCT INFORMATION

CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician.

INDICATIONS: The AcrySof® IQ aspheric intraocular lens (“AcrySof IQ”) is intended for the replacement of the human lens to achieve visual correction of aphakia in adult patients following cataract surgery. This lens is intended for placement in the capsular bag.

WARNING/PRECAUTION: Use the UltraSert Pre-loaded Delivery System (“UltraSert”) at temperatures between 18o C (64o F) and 23oC (73o F). Use only Alcon viscoelastic qualified for this device. Do not use the UltraSert if the nozzle appears damaged or deformed. Follow the Directions for Use for correct order and sequence of steps to avoid damage to the IOL or the UltraSert.

Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use. Caution should be used prior to lens encapsulation to avoid lens decentrations or dislocations.

Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof® Natural IOL and normal color vision. The effect on vision of the AcrySof® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45o C.

ATTENTION: Reference the Directions for Use for Model AU00T0 for a complete listing of indications, warnings and precautions.

Click here to view the AcrySof® IQ IOL with the UltraSert Preloaded IOL Delivery System Directions For Use (DFU).